Orla Mining (ORLA) has had the highest return since February 2, 2025 by a mid-cap US stock, returning 53.2%.
| ASSET | % RETURN |
|---|---|
Orla Mining (ORLA) | 53.21% |
Celsius (CELH) | 53.13% |
Soleno Therapeutics (SLNO) | 50.5% |
Liberty Global PLC Class B (LBTYB) | 50.37% |
Zai Lab (ZLAB) | 36.6% |
Veren (VRN) | 36.33% |
Sandisk (SNDK) | 35.97% |
Palomar (PLMR) | 35.66% |
Kanzhun Ltd ADR (BZ) | 33.61% |
Mr Cooper (COOP) | 31.6% |
Lufax (LU) | 31.3% |
D-Wave Quantum (QBTS) | 30.37% |
Protagonist Therapeutics (PTGX) | 29.99% |
Harmony Gold Mining (HMY) | 29.9% |
TG Therapeutics (TGTX) | 29.37% |
Ascentage Pharma Group International (AAPG) | 29.21% |
Corcept Therapeutics (CORT) | 28.74% |
Compass (COMP) | 28.47% |
ADMA Biologics (ADMA) | 28.44% |
Sandstorm Gold Ltd N (SAND) | 28.03% |
Embotelladora Andina (AKO.A) | 26.94% |
Compania Cervecerias Unidas SA ADR (CCU) | 26.54% |
SolarWinds (SWI) | 26.41% |
SpringWorks Therapeutics (SWTX) | 25.97% |
SSR Mining (SSRM) | 25.63% |
Mid-cap stocks are treated as having a market cap between $2B and $10B.
